𝔖 Bobbio Scriptorium
✦   LIBER   ✦

New blood-based biomarkers for the diagnosis, staging and prognosis of prostate cancer

✍ Scribed by Shahrokh F. Shariat; Jose A. Karam; Vitaly Margulis; Pierre I. Karakiewicz

Book ID
109053651
Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
106 KB
Volume
101
Category
Article
ISSN
1464-4096

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Use of multiple biomarkers for a molecul
Use of multiple biomarkers for a molecular diagnosis of prostate cancer
✍ Kelly A. Landers; Michelle J. Burger; Michelle A. Tebay; David M. Purdie; Betty πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 French βš– 164 KB

## Abstract The identification of biomarkers capable of providing a reliable molecular diagnostic test for prostate cancer (PCa) is highly desirable clinically. We describe here 4 biomarkers, __UDP__‐__N__‐__Acetyl__‐α‐__D__‐__galactosamine transferase__ (__GalNAc__‐__T3__; not previously associate

Measurement of free PSA in the diagnosis
Measurement of free PSA in the diagnosis and staging of prostate cancer
✍ Juan Morote; Carles X. RaventΓ³s; JosΓ© A. Lorente; Miguel A. Lopez-Pacios; Gloria πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 French βš– 57 KB πŸ‘ 2 views

The purpose of this study was to analyze the role of total prostate-specific-antigen (PSA) and free-PSA levels in the diagnosis and clinical staging of prostate cancer. We determined total-PSA serum concentration and free-PSA percentage in 352 patients, 234 with benign prostatic hyperplasia (BPH) an

Investigating FTIR based histopathology
Investigating FTIR based histopathology for the diagnosis of prostate cancer
✍ Matthew J. Baker; Ehsan Gazi; Michael D. Brown; Jonathan H. Shanks; Noel W. Clar πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 497 KB

## Abstract Prostate cancer is the most common gender specific cancer. The current gold standard for diagnosis, histopathology, is subjective and limited by variation between different pathologists. The diagnostic problems associated with the correct grading and staging of prostate cancer (CaP) has